| Literature DB >> 32148662 |
Faizanahmed Munshi1, Brian M Shinder1, Evita Sadimin2, Tina M Mayer3, Eric A Singer1.
Abstract
Prostate cancer metastases are commonly seen in the skeleton, lymph nodes, lungs, or liver, and are associated with a poor five-year survival rate. Renal pelvis and ureteral metastasis are exceedingly uncommon and can present with obstructive symptoms or as an asymptomatic mass on imaging. We report the case of a 60-year-old patient who was initially diagnosed with prostate adenocarcinoma and experienced eventual metastasis to the right renal pelvis and proximal ureter. Following the diagnosis, he was started on docetaxel and pembrolizumab as part of a clinical trial protocol. A high index of suspicion and thorough metastatic work-up is necessary when patients with prostate cancer present with symptoms of obstructive uropathy or new visceral disease is identified.Entities:
Keywords: hydronephrosis; metastatic prostate cancer; prostate cancer; renal pelvis metastasis; ureteral metastasis
Year: 2019 PMID: 32148662 PMCID: PMC7059776
Source DB: PubMed Journal: Cancer Stud Ther